Bioenergy Nutrients Respiratory Claims Cited In FDA Courtesy Letter
This article was originally published in The Tan Sheet
Executive Summary
Three of five products marketed by Amrion's Bioenergy Nutrients division were cited in a May 22 FDA "courtesy" letter for making structure/function claims referring to "respiratory disorders."
You may also be interested in...
Cognis Prevastein "Bone Health" Claim Cleared By FDA
Cognis Nutrition & Health is preparing to introduce its Prevastein soy isoflavone ingredient for post-menopausal "bone health" following resolution with FDA of potential structure/function claim language.
Cognis Prevastein "Bone Health" Claim Cleared By FDA
Cognis Nutrition & Health is preparing to introduce its Prevastein soy isoflavone ingredient for post-menopausal "bone health" following resolution with FDA of potential structure/function claim language.
Cognis Prevastein "Bone Health" Claim Cleared By FDA
Cognis Nutrition & Health is preparing to introduce its Prevastein soy isoflavone ingredient for post-menopausal "bone health" following resolution with FDA of potential structure/function claim language.